Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

No genetic association between postsynaptic density-95 gene polymorphisms and schizophrenia.

Ritsuko Kawashima1, Tohru Ohnuma, Nobuto Shibata

  • 1Department of Psychiatry, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan. ritsukok@med.juntendo.ac.jp

Neuroscience Letters
|March 15, 2006
PubMed
Summary

This study investigated the role of postsynaptic density-95 gene polymorphisms in schizophrenia. The findings indicate that these specific genetic variations do not influence schizophrenia risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid Positron Emission Tomography Imaging at the Onset of Amyloid-Related Abnormalities With Edema in an Alzheimer's Disease Patient.

Cureus·2026
Same author

MRI-Based Medial Temporal Atrophy May Reflect Amyloid PET Positivity in Cognitively Normal Individuals: A Preliminary Study.

Cureus·2025
Same author

Validation of the Japanese version of MemScreen: a rapid screening tool for mild cognitive impairment.

Environmental health and preventive medicine·2025
Same author

Underestimated Centiloid Values in Amyloid PET: A Technical Report on Clinically Relevant Quantification Errors.

Cureus·2025
Same author

Mental illness knowledge and the intention to seek psychiatric treatment among college athletes: use of a two-axis matrix to assess a new method of mental health support.

BMJ open·2025
Same author

Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Schizophrenia pathophysiology may involve disrupted glutamatergic neurotransmission, particularly N-methyl-D-aspartate (NMDA) receptor function.
  • Intracellular signaling pathways linked to NMDA receptors and synaptic plasticity, involving postsynaptic density-95 (PSD-95), may also be implicated.
  • Previous research indicated altered PSD-95 gene expression in schizophrenic brains.

Purpose of the Study:

  • To investigate the association between six polymorphisms in the PSD-95 gene and schizophrenia risk.
  • To determine if genetic variations in PSD-95 contribute to the pathophysiology of schizophrenia.

Main Methods:

  • Genotyping of six single nucleotide polymorphisms (SNPs) within and around the PSD-95 gene.
  • Utilized TaqMan technology for genotyping.

Related Experiment Videos

  • Study included 259 individuals diagnosed with schizophrenia and 188 healthy controls.

    • Main Results:

    • Analysis of the six examined polymorphisms in the PSD-95 gene showed no significant association with schizophrenia.
    • The investigated genetic variations did not appear to alter the risk of developing schizophrenia.

    Conclusions:

    • The specific PSD-95 gene polymorphisms studied do not seem to be risk factors for schizophrenia.
    • Further research may be needed to explore other genetic or environmental factors in schizophrenia etiology.